BeyondSpring BYSI Q1 2026 Earnings Narrowing Loss and No Revenue as ClinicalStage Biotech Advances Pipeline TEX Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher TEM Q1 2026 Earnings EPS Beats Estimates by 328 Amidst Revenue Data Gap XOMAP Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Royalty Fluctuations TScan Therapeutics Q1 2026 Earnings Narrowing Loss Despite EPS Miss Stock Gains on Pipeline Progress DOO Q1 2026 Earnings EPS Surprise of 796 Lifts Shares